Evidence of proatherogenic inflammation in polycystic ovary syndrome.
Evidence of proatherogenic inflammation in polycystic ovary syndrome.
复制标题
DOI:
10.1016/j.metabol.2009.02.022
复制
发表时间:
2009-07
影响因子:
9.8
通讯作者:
Kirwan, John P.
中科院分区:
文献类型:
--
作者:
Gonzalez, Frank;Rote, Neal S.;Minium, Judi;Kirwan, John P.
Women with Polycystic Ovary Syndrome (PCOS) have chronic low level inflammation which can increase the risk of atherogenesis. We measured circulating proatherogenic inflammatory mediators in women with PCOS (8 lean - BMI, 18–25 kg/m2, 8 obese -BMI, 30–40 kg/m2) and weight-matched controls (8 lean, 8 obese). Blood samples were obtained fasting and 2 hours after glucose ingestion to measure interleukin-6 (IL-6), soluble intercellular adhesion molecule-1 (sICAM-1), monocyte chemotactic protein-1 (MCP-1), C-reactive protein (CRP), matrix metalloproteinase-2 (MMP-2), plasminogen activator inhibitor-1 (PAI-1), and activated nuclear factor κB (NFκB) in mononuclear cells. Truncal fat was determined by DEXA. Fasting MCP-1 levels were elevated in lean women with PCOS compared to lean controls (159.9±14.1 vs. 121.2±5.4 pg/ml, p<0.02). Hyperglycemia failed to suppress MMP-2 in lean women with PCOS compared to lean controls (1.7±1.2 vs. −4.8±1.6 pg/ml, p<0.002). Among women with PCOS, obese individuals exhibited higher fasting sICAM-1 (16.1±0.8 vs. 10.5±1.0 ng/ml, p<0.03) and PAI-1 (6.1±0.7 vs. 3.4±0.8 ng/ml, p<0.03) levels. Trend analysis revealed higher (p<0.005) IL-6, sICAM-1, CRP and PAI-1, systolic and diastolic blood pressures, triglycerides, fasting insulin and HOMA-IR in women with PCOS compared to weight-matched controls, and the highest levels in the obese regardless of PCOS status. Fasting MCP-1 levels correlated with activated NFκB during hyperglycemia (p<0.05) and androstendione (p<0.004). Truncal fat correlated with fasting IL-6 (p<0.004), sICAM-1 (p<0.006), CRP (p<0.0009) and PAI-1 (p<0.02). We conclude that both PCOS and obesity contribute to a proatherogenic state, but in women with PCOS, abdominal adiposity and hyperandrogenism may exacerbate the risk of atherosclerosis.
登录
查看更多内容
影响因子:
8.7
作者:
ADAMS, MR;WILLIAMS, JK;KAPLAN, JR
通讯作者:
KAPLAN, JR
影响因子:
5.8
作者:
Boulman, N;Levy, Y;Blumenfeld, Z
通讯作者:
Blumenfeld, Z
影响因子:
5.8
作者:
Lewandowski, KC;Komorowski, J;Randeva, HS
通讯作者:
Randeva, HS
影响因子:
5.8
作者:
Knochenhauer, ES;Key, TJ;Azziz, R
通讯作者:
Azziz, R
影响因子:
5.8
作者:
González, F;Rote, NS;Kirwan, JP
通讯作者:
Kirwan, JP